IL-6/gp130 signaling: a key unlocking regeneration.


Journal

Cell regeneration (London, England)
ISSN: 2045-9769
Titre abrégé: Cell Regen
Pays: China
ID NLM: 101627311

Informations de publication

Date de publication:
23 Mar 2023
Historique:
entrez: 23 3 2023
pubmed: 24 3 2023
medline: 24 3 2023
Statut: epublish

Résumé

Liver is an organ with notable capacity of regeneration. Reprogramming of hepatocytes towards an immature state is one of the important mechanisms for hepatocyte replenishment. Inflammatory response mediated by IL-6 and its family cytokines has been widely reported closely related with tissue regeneration in myriads of organs. Recently Hui and colleagues reported that the dedifferentiation of hepatocytes depends upon IL-6 signaling from Kupffer cells and the reprogramming of gene expression under the inflammatory condition is different from the regulation of gene expression during embryo hepatocyte specification, highlighting a tight linkage between extracellular microenvironment and parenchymal cell plasticity during tissue regenerative repair.

Identifiants

pubmed: 36952066
doi: 10.1186/s13619-023-00160-z
pii: 10.1186/s13619-023-00160-z
pmc: PMC10036683
doi:

Types de publication

Journal Article

Langues

eng

Pagination

16

Informations de copyright

© 2023. The Author(s).

Références

J Mol Cell Cardiol. 2019 Feb;127:105-114
pubmed: 30553885
Cell. 2020 Mar 5;180(5):833-846.e16
pubmed: 32142677
Cell Rep. 2020 Dec 8;33(10):108472
pubmed: 33296652
Cell Mol Immunol. 2021 Feb;18(2):492-494
pubmed: 32055006
Nature. 2009 Jan 8;457(7226):200-4
pubmed: 19020503
Sci Adv. 2021 Sep 10;7(37):eabg6497
pubmed: 34516874
Cell Stem Cell. 2019 Jul 3;25(1):54-68.e5
pubmed: 31271748
J Mol Cell Cardiol. 2023 Feb 16;177:1-8
pubmed: 36801268
Circulation. 2020 Sep 8;142(10):967-982
pubmed: 32600062
Nature. 2015 Mar 5;519(7541):57-62
pubmed: 25731159
Cell Res. 2015 Oct;25(10):1137-51
pubmed: 26358185
Cell Stem Cell. 2023 Mar 2;30(3):283-299.e9
pubmed: 36787740

Auteurs

Ruopu Li (R)

State Key Laboratory of Cardiovascular Disease, Fuwai Hospital & Cardiovascular Institute, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, 167 Street, Beilishi Road, Xicheng District, 100037, Beijing, People's Republic of China.

Deqiang Li (D)

The Center for Cardiovascular Research, the Research Institute at Nationwide Children's Hospital, 575 Children's Drive, Columbus, OH, 43215, USA.
The Department of Pediatrics, College of Medicine, Ohio State University, Columbus, OH, 43215, USA.

Yu Nie (Y)

State Key Laboratory of Cardiovascular Disease, Fuwai Hospital & Cardiovascular Institute, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, 167 Street, Beilishi Road, Xicheng District, 100037, Beijing, People's Republic of China. nieyu@fuwaihospital.org.
National Health Commission Key Laboratory of Cardiovascular Regenerative Medicine, Fuwai Central-China Hospital, Central China Branch of National Center for Cardiovascular Diseases, 450046, Zhengzhou, China. nieyu@fuwaihospital.org.
Shenzhen Key Laboratory of Cardiovascular Disease, Fuwai Hospital Chinese Academy of Medical Sciences, 518057, Shenzhen, China. nieyu@fuwaihospital.org.

Classifications MeSH